Inventor · disambiguated record
Ravinder N. Maini
Also filed as: MAINI RAVINDER N · MAINI RAVINDER NATH
10 granted patents·14 pending applications·585 citations·filing 1993–2021
92Inventor score
Files withKENNEDY INST OF RHEUMATOLOGY10CHUGAI PHARMACEUTICAL CO LTD6KENNEDY RHEUMATOLOGY INST3FELDMANN MARC2CENTOCOR INC1
Top patents by PatentIndex Score
24 records- 0197US7521052B2Methods for treating interleukin-6 related diseasesCHUGAI PHARMACEUTICAL CO LTD·Filed 2004·Granted Apr 21, 2009·92 cites·1 claims
- 0297US6270766B1Anti-TNF antibodies and methotrexate in the treatment of arthritis and crohn's diseaseKENNEDY INST OF RHEUMATOLOGY·Filed 1996·Granted Aug 7, 2001·208 cites·30 claims
- 0395US10744201B2Method for treating rheumatoid arthritis with a human IL-6 receptor antibody and methotrexateCHUGAI PHARMACEUTICAL CO LTD·Filed 2018·Granted Aug 18, 2020·6 cites·15 claims
- 0495US7846442B2Methods of treating rheumatoid arthritis with an anti-TNF-alpha antibodies and methotrexateKENNEDY RHEUMATOLOGY INST·Filed 2005·Granted Dec 7, 2010·26 cites·22 claims
- 0595US5741488ATreatment of rheumatoid arthritis with anti-CD4 antibodies in conjunction with anti-TNF antibodiesKENNEDY INST OF RHEUMATOLOGY·Filed 1993·Granted Apr 21, 1998·203 cites·6 claims
- 0694US7838489B2Methods of treating rheumatoid arthritis with p75 TNF-alpha receptor and methotrexateKENNEDY RHEUMATOLOGY INST·Filed 2008·Granted Nov 23, 2010·20 cites·10 claims
- 0782US8298537B2Concomitant treatment of rheumatoid arthritis with anti-TNF-α antibodies and methotrexateFELDMANN MARC·Filed 2012·Granted Oct 30, 2012·5 cites·30 claims
- 0877US2021283250A1Method for treating rheumatoid arthritis with a human il-6 receptor antibody and methotrexateCHUGAI PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 0975US8383120B2Concomitant treatment of rheumatoid arthritis with anti-TNF-alpha antibodies and methotrexateKENNEDY RHEUMATOLOGY INST·Filed 2012·Granted Feb 26, 2013·1 cites·19 claims
- 1074US2021170024A1Method for treating rheumatoid arthritis with a human il-6 receptor antibody and methotrexateCHUGAI PHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
- 1170US2011123543A1TNFalpha antagonists and methotrexate in the treatment of TNF-mediated diseaseKENNEDY INST OF RHEUMATOLOGY·Filed 2009·Application pending·0 cites
- 1270US2011014188A1TNFalpha antagonists and methotrexate in the treatment of TNF-mediated diseaseKENNEDY INST OF RHEUMOTOLOGY·Filed 2009·Application pending·0 cites
- 1367US2009263388A1Methods of preventing or treating cardiovascular, cerebrovascular and thrombotic disorders with tumor necrosis factor antagonistsKENNEDY INST OF RHEUMATOLOGY·Filed 2009·Application pending·0 cites
- 1466US2015010554A1Methods for treating interleukin-6 related diseasesCHUGAI PHARMACEUTICAL CO LTD·Filed 2014·Application pending·0 cites
- 1564US2014017236A1Methods for treating interleukin-6 related diseasesCHUGAI PHARMACEUTICAL CO LTD·Filed 2013·Application pending·0 cites
- 1660US6770279B1TNFα antagonists and cyclosporin in therapy of rheumatoid arthritisKENNEDY INST OF RHEUMATOLOGY·Filed 1998·Granted Aug 3, 2004·18 cites·2 claims
- 1759US2013064816A1TNF-alpha ANTAGONISTS AND METHOTREXATE IN THE TREATMENT OF TNF-MEDIATED DISEASEFELDMANN MARC·Filed 2012·Application pending·0 cites
- 1859US2004228863A1Treatment of tumor necrosis factor-mediated diseasesKENNEDY INST OF RHEUMATOLOGY·Filed 2004·Application pending·0 cites
- 1953US2002136723A1Anti-TNF antibodies and methotrexate in the treatment of autoimmune diseaseKENNEDY INST OF RHEUMATOLOGY·Filed 2001·Application pending·0 cites
- 2052US2002010180A1TNFalpha antagonists and methotrexate in the treatment of TNF-mediated diseaseKENNEDY INST OF RHEUMATOLOGY·Filed 2001·Application pending·0 cites
- 2143US2007178099A1Suppression of TNFalpha and IL-12 in therapyKENNEDY INST OF RHEUMATOLOGY·Filed 2007·Application pending·0 cites
- 2243US2003064070A1Multiple administrations of anti-TNF antibodyCENTOCOR INC·Filed 2002·Application pending·0 cites
- 2339US7608262B2Methods of preventing or treating thrombosis with tumor necrosis factor antagonistsKENNEDY INST OF RHEUMATOLOGY·Filed 1996·Granted Oct 27, 2009·6 cites·1 claims
- 2429US2002068057A1Treatment of autoimmune and inflammatory disordersFiled 1994·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ravinder N. Maini files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →